John E Porterfield
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2018First federal award
$8.4MFederal grants as PI13 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
13 awards · $8.4M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 24, 2026 | NIH | SBIR Phase I A Right Heart Catheter for Pressure-Volume Loop Risk Stratification for Percutaneous Valve Repair in Tricuspid Regurgitation | $321K | BRIDGESOURCE MEDICAL, CORP. |
| Aug 30, 2024 | NIH | SBIR Phase II Novel Device to Optimize Aerosol Drug Delivery for Pulmonary Hypertension Treatment | $875K | BRIDGESOURCE MEDICAL, CORP. |
| Aug 23, 2023 | NIH | SBIR Phase II Novel Device to Optimize Aerosol Drug Delivery for Pulmonary Hypertension Treatment | $1.0M | BRIDGESOURCE MEDICAL, CORP. |
| Jul 10, 2023 | NIH | SBIR Phase II Technology-Enabled Financial Planning for Caregivers and Clients with Reduced Capacity | $998K | BRIDGESOURCE MEDICAL, CORP. |
| Jun 23, 2023 | NIH | SBIR Phase II Native Hemodynamic Measurement as Feedback Control for Mechanical Cardiac Support | $1.2M | BRIDGESOURCE MEDICAL, CORP. |
| Aug 2, 2022 | NIH | SBIR Phase II Technology-Enabled Financial Planning for Caregivers and Clients with Reduced Capacity | $980K | BRIDGESOURCE MEDICAL, CORP. |
| Jun 14, 2022 | NIH | SBIR Phase II Native Hemodynamic Measurement as Feedback Control for Mechanical Cardiac Support | $499K | BRIDGESOURCE MEDICAL, CORP. |
| Sep 21, 2021 | NIH | SBIR Phase II Technology-Enabled Financial Planning for Caregivers and Clients with Reduced Capacity | $300K | BRIDGESOURCE MEDICAL, CORP. |
| Jul 27, 2020 | NIH | SBIR Phase I Novel Device used to Optimize Aerosol Drug Delivery for Pulmonary Hypertension Treatment | $252K | BRIDGESOURCE MEDICAL, CORP. |
| Jun 24, 2020 | NIH | SBIR Phase II Universal Medical Device Identifier to Improve Emergency Triage | $830K | BRIDGESOURCE MEDICAL, CORP. |
| Jul 15, 2019 | NIH | SBIR Phase II Universal Medical Device Identifier to Improve Emergency Triage | $670K | BRIDGESOURCE MEDICAL, CORP. |
| May 3, 2019 | NIH | SBIR Phase I Native Hemodynamic Measurement as Feedback Control for Mechanical Cardiac Support | $225K | BRIDGESOURCE MEDICAL, CORP. |
| Apr 23, 2018 | NIH | SBIR Phase I Universal Medical Device Identifier | $225K | BRIDGESOURCE MEDICAL, CORP. |
Peer ranks
Federal funding#109
Awards as PI#77
Patents#505
Companies
- BRIDGESOURCE MEDICAL, CORP.Linked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.